Showing results (541-550 of 703) with videos related to

Sort By:
Pageof 71
British Journal of Haematology|July 6, 2016
Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantationGunjan L Shah, Joachim Yahalom, Matthew J Matasar, et al.
Blood|September 26, 2000
High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysisT Kewalramani, A D Zelenetz, E E Hedrick, et al.
Retina (Philadelphia, Pa.)|January 29, 2021
SENIOR-LØKEN SYNDROME: A Case Series and Review of the Renoretinal Phenotype and Advances of Molecular DiagnosisClaudia Yahalom, Oded Volovelsky, Michal Macarov, et al.
Microbiology Spectrum|October 31, 2022
HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection StateTom Domovitz, Samer Ayoub, Michal Werbner, et al.
Life (Basel, Switzerland)|June 26, 2025
Prodromal Parkinsonian Features in Carriers of Gaucher Disease Compared to ControlsMichal Becker-Cohen, Ari Zimran, Tama Dinur, et al.
Current Issues in Molecular Biology|October 27, 2023
Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2Noam Erez, Hagit Achdout, Yfat Yahalom-Ronen, et al.
Parkinsonism & Related Disorders|August 13, 2013
The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's diseaseLior Greenbaum, Simon D Israeli-Korn, Oren S Cohen, et al.
Frontiers in Immunology|July 18, 2018
The Ebola-Glycoprotein Modulates the Function of Natural Killer CellsAvishay Edri, Avishai Shemesh, Muhammed Iraqi, et al.
BMC Cancer|November 1, 2025
BRAF mutations and targeted therapy in unclassified pericytic tumors: insights from genetic analysis and clinical responseHana Golan, Moshe Leitner, Marilena Vered, et al.
Journal of Neuro-Oncology|August 5, 2019
Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantationDenise D Correa, Erica Braun, Maria Kryza-Lacombe, et al.
Pageof 71